Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Digital Health Trends 2024 - Implications for Research and Patient Care

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • IQVIA AI Assistant
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience Solutions with Apple devices
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Meet the IQVIA AI Assistant

Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions with Apple devices

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.

LEARN MORE
MAIN/Careers
Careers/
IQVIA Careers
Featured Careers
Stay Connected

WE'RE HIRING

"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.

VIEW ROLES
MAIN/Contact Us
Contact Us/
Blog
The Future of Pricing Transparency Legislation Promises More Complexity
Mark Scallon, Senior Principal, Commercial Compliance
Jun 04, 2019
  • Blogs
  • The Future of Pricing Transparency Legislation Promises More Complexity

The increase in regulatory activity around pricing transparency sends a strong message to the Life Sciences market that manufacturers dismiss at their own risk. Industry participants must adopt proactive strategies to address a wave of new regulations which are designed to limit drug costs by requiring transparency reporting on drug prices and drug price increases. This could be the precursor to more invasive regulatory measures such as government mandated pricing controls. In order to prepare for the additional complexity that is sure to come, manufacturers need a flexible, compliance-based framework that is robust enough to encompass the new regulations that are emerging from states, and scalable enough to accommodate the expectation of eventual Federal involvement in the manner of the CMS’s Open Payments program.

Several states now require some level of price reporting, and there are bills making their way through the legislative process in a number of others — and the only consistent factor is a lack of consistency between their legislative approaches. Some track wholesale acquisition cost (WAC) prices, while some mandate reporting around average manufacturer price (AMP). And a growing number of states have gone beyond these statutorily defined price types, crafting legislation that requires disclosure and reporting of considerably more detailed, granular and even proprietary metrics like product marketing costs, development and input costs.

Each state’s exact reporting requirements and timelines for compliance vary. Just a few examples: In Nevada, reporting of state price transparency and HCP transparency are covered in a single law, creating a dual compliance mandate. Starting this year in California, manufacturers are required to submit notification of price increases 60 days prior to the anticipated change. And in New York, manufacturers of “high spend drugs” are subject to additional requirements — and penalties for noncompliance.

If Federal regulators decide to return to the playbook they used when developing the CMS Open Payments platform, which is likely, that would mean yet another set of different instructions, mandates and procedures for companies to follow.

Although some states have committed to keeping pricing control and transparency data confidential, others have announced their intent to make this information public, just as the Centers for Medicare and Medicaid Open Payments website does at the Federal level. The key difference between spend transparency reporting requirements and price transparency reporting — and the key challenge — is that the marketplace is evolving so that not only government agencies, but competing manufacturers and even consumers could access price transparency reporting data.

Any errors in reporting, even if inadvertent, threaten to expose pharmaceutical companies to regulatory sanctions, penalties and increased oversight. Since drug prices are a sociopolitical issue on an ascendant trajectory, the industry also is vulnerable to public and media scrutiny. Focusing on data integrity and data quality to produce consistent, correct and compliance-focused price transparency reporting can help manufacturers avoid a potential P.R. nightmare.

There is a growing acknowledgement that the legislation in place today is just the tip of the iceberg. Manufacturers today need to proceed with the expectation that these regulatory protocols will only increase and broaden in scale and scope over time. The trajectory of this legislative imperative in the aggregate is very similar to the early stages of spend transparency reporting. As such, it is reasonable to expect the evolution to reflect that of spend transparency reporting, with concurrent activity by states followed by involvement at the federal, and then the global level.

It is still early enough to get out in front of the burgeoning demands around price transparency reporting, but the window to successfully do so is becoming small. Manufacturers need to implement a compliance-focused infrastructure to establish consistent processes and controls.

Being able to identify relevant pricing data across disparate systems is a challenge that needs a comprehensive, compliance-focused strategy. Companies need to commit to investing in this challenge, and work with partners capable of building out efficient processes to make this growing obligation to report price increases more seamless.

For more information about IQVIA Commercial Compliance, please e-mail commercialcompliance@iqvia.com or visit our webpage. Our experts leverage the industry’s leading technologies to deliver streamlined processes and improved efficiencies that solve your toughest engagement and transparency challenges. From automating and managing the entire HCP/O contracting lifecycle, to capturing, collecting, and reporting global spend; to planning efficient and compliant HCP meetings and engagements—discover how our solutions can make compliance easier for you.

Contact Us